XNAS
RCMT
Market cap198mUSD
Jul 09, Last price
27.94USD
1D
1.05%
1Q
3.75%
Jan 2017
339.31%
Name
R C M Technologies Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
RCM Technologies, Inc. delivers business and technology-focused solutions across the United States, Canada, Puerto Rico, and Serbia. The company organizes its operations into three distinct divisions: Engineering, Specialty Health Care, and Life Sciences and Information Technology. The Engineering division provides diverse services, including project management, design, analytical work, engineer-procure-construct (EPC) services, configuration management, hardware/software validation and verification, quality assurance, technical documentation, manufacturing process optimization, and integrated 3D/BIM design. Within its Specialty Health Care unit, RCM offers both temporary and permanent staffing, executive recruitment, and placement services. These cater to various healthcare domains such as allied health and therapy, correctional healthcare, health information management, nursing, physician and advanced practice roles, school services, and telepractice. The Life Sciences and Information Technology segment concentrates on supplying comprehensive enterprise business solutions, application services, robust infrastructure solutions, strategies for competitive advantage, specialized life sciences offerings, and tailored solutions for other specific vertical markets. RCM Technologies serves a broad spectrum of industries, including aerospace and defense, energy, financial services, healthcare, life sciences, manufacturing and distribution, and technology. Additionally, their clientele extends to educational institutions and governmental bodies. Founded in 1971, RCM Technologies, Inc. is headquartered in Pennsauken, New Jersey.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑00 | 2024‑12 | 2023‑12 | 2023‑12 | 2022‑12 | 2022‑00 | 2021‑12 | 2021‑00 | 2020‑12 | 2019‑12 | 2019‑12 | 2018‑12 | 2018‑12 | 2017‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||||||
Revenues | ||||||||||||||||
Cost of revenue | ||||||||||||||||
Unusual Expense (Income) | ||||||||||||||||
NOPBT | ||||||||||||||||
NOPBT Margin | ||||||||||||||||
Operating Taxes | ||||||||||||||||
Tax Rate | ||||||||||||||||
NOPAT | ||||||||||||||||
Net income | ||||||||||||||||
Dividends | ||||||||||||||||
Dividend yield | ||||||||||||||||
Proceeds from repurchase of equity | ||||||||||||||||
BB yield | ||||||||||||||||
| Debt | ||||||||||||||||
Debt current | ||||||||||||||||
Long-term debt | ||||||||||||||||
Deferred revenue | ||||||||||||||||
Other long-term liabilities | ||||||||||||||||
Net debt | ||||||||||||||||
| Cash flow | ||||||||||||||||
Cash from operating activities | ||||||||||||||||
CAPEX | ||||||||||||||||
Cash from investing activities | ||||||||||||||||
Cash from financing activities | ||||||||||||||||
FCF | ||||||||||||||||
| Balance | ||||||||||||||||
Cash | ||||||||||||||||
Long term investments | ||||||||||||||||
Excess cash | ||||||||||||||||
Stockholders' equity | ||||||||||||||||
Invested Capital | ||||||||||||||||
ROIC | ||||||||||||||||
ROCE | ||||||||||||||||
| EV | ||||||||||||||||
Common stock shares outstanding | ||||||||||||||||
Price | ||||||||||||||||
Market cap | ||||||||||||||||
EV | ||||||||||||||||
EBITDA | ||||||||||||||||
EV/EBITDA | ||||||||||||||||
Interest | ||||||||||||||||
Interest/NOPBT | ||||||||||||||||